New TB-resistant cows developed in China

Image
IANS Beijing
Last Updated : Feb 01 2017 | 5:49 PM IST

In a first, Chinese scientists have used a novel version of the CRISPR gene-editing technology to successfully produce live cows with increased resistance to bovine tuberculosis (TB).

The researchers from Northwest A&F University in China used a modified version of the CRISPR system called CRISPR/Cas9n to insert a new TB resistance gene -- NRAMP1 -- into the genome of bovine foetal fibroblasts -- a cell derived from female dairy cows.

"We used a novel version of the CRISPR system to successfully insert a TB resistance gene into the cow genome. We were then able to successfully develop live cows carrying increased resistance to TB," said led author Yong Zhang.

These cells were then used as donor cells in a process called somatic cell nuclear transfer, where the nucleus of a donor cell carrying the new gene is inserted into an egg cell, known as an ovum, from a female cow.

These ovum were then nurtured in the lab into embryos before being transferred into mother cows for a normal pregnancy cycle, in which cows were produced with no off target effects on the animals' genetics -- a common problem when creating transgenic animals using CRISPR.

"Importantly, our method produced no off target effects on the cow genetics meaning the CRISPR technology we employed may be better suited to producing transgenic livestock with purposefully manipulated genetics," Zhang added in the study published in the journal Genome Biology.

For the study, the team used CRISPR to insert the new gene in 11 calves.

The results revealed that NRAMP1 had successfully integrated into the genetic code at the targeted region in all of the calves.

When exposed to Mycobacterium bovis (M. bovis) -- the bacterium that causes bovine TB -- the transgenic animals showed an increased resistance to the bacteria measured by standard markers of infection in a blood sample.

Further, white blood cells taken from the calves also showed much resistance to M. bovis exposure in laboratory tests.

--IANS

rt/py/vt

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 01 2017 | 5:36 PM IST

Next Story